Mizina/iStock via Getty Images Beauty Health (NASDAQ:SKIN) emerged from the pandemic with material momentum behind it as global demand for HydraFacial, its patented non-invasive skincare treatment, ramped up. This meant the company’s run to a 52-week high of $30.17 had real legs as it was built on the back of sound financials, most notably the…
